What are the connections between cannabis use and the onset of psychotic disorders?
New data from the Suicide and Trauma Reduction Initiative for Veterans at Ohio State University indicates the most effective interventions to prevent suicide risk among veterans.
How can clinicians distinguish between ordinary grief, depression, and prolonged grief disorder?
Insights and inspiration shared from a presentation on serving marginalized communities at the 2023 American Psychiatric Association Annual Meeting,
Efforts are underway to design and advance solutions to disinformation.
Here’s how to help patients see the light when faced with the winter blues.
Mental health clinicians and legal practitioners can learn more about parental alienation and its treatment here.
How can we face the current pandemic while addressing the brain health crisis?
New research reveals that discontinuing long-term benzodiazepine therapy may increase risks of mortality and other adverse outcomes, challenging common assumptions.
What treatments were recently approved by the US Food and Drug Administration for pediatric patients with ADHD?
Transgender and gender-diverse youth experience higher rates of depression, suicidal behaviors, and self-injury than their cisgender peers. Here's what you need to know.
In this guest column, learn more about intensity, repetition, consistency, and integrity in rehabilitating neurological injury.
Each Native American tribe has a specific history, traditions, customs, and culture, and knowing something of these will help build the physician-patient relationship.
What is lifestyle psychiatry, and how can it benefit our patients?
If depression impairs the brain’s processes at a molecular level, would the same be true of stress more generally?
Although estimates vary, patients with cancer are at least twice as likely to die by suicide than people who do not have cancer. By identifying those at greatest risk, these treatment modalities can help support patients.
D-cycloserine may help patients with anxiety disorders, or it might make their anxiety worse. Find out how to use it safely.
Numinus' Chief Clinical Officer shares resources about the potential use of ketamine in psychiatry.
Machine learning may help science better understand cognitive impairment in schizophrenia and improve prevention and patient care.
How can you best address and support transgender patients, as well as prevent negative outcomes?
Psychiatry must embrace media to combat misinformation, shared Mena Mirhom, MD, FAPA, at the 2025 APA Annual Meeting.
A recent study tested a new digital therapeutic for effectiveness on both substance abuse and depression.
In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.
Sleep deprivation among health care workers: a growing concern.
With more immigrant students enrolling in US colleges, what can we do to help with their transition?
Jelena Kunovac, MD, MS, discusses last week's approval of Cobenfy, an agent with a novel mechanism of action that could revolutionize schizophrenia treatment.
The Lancet Commission report on nonfatal self-harm identifies key challenges, causes, and more.